Trials / Completed
CompletedNCT00262275
Optimum Platelet Inhibition After Coronary Bypass Surgery
Optimum Platelet Inhibition After Coronary Artery Bypass Surgery: A Randomised Trial Comparing Platelet Aggregation Using Low, Medium Dose Aspirin and Clopidogrel
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Papworth Hospital NHS Foundation Trust · Other Government
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To investigate the effect of different dosages of aspirin on platelet aggregation and to determine the possible mechanisms of aspirin resistance, we intend to compare the effects of low, medium dose aspirin with clopidogrel (an alternative antiplatelet agent) in patients after coronary artery bypass surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Aspirin, Clopidogrel |
Timeline
- Start date
- 2002-07-01
- Primary completion
- 2004-07-01
- First posted
- 2005-12-06
- Last updated
- 2016-01-22
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT00262275. Inclusion in this directory is not an endorsement.